Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
Merkel cell carcinoma (MCC) is a highly lethal skin cancer. MCC tumors rapidly develop resistance to the chemotherapies tested to date. While PD-1/PD-L1 immune checkpoint blockade has demonstrated success in MCC treatment, a significant portion of MCC patients are nonresponsive. Therefore, the press...
Main Authors: | Wei Liu, Nathan A. Krump, Meenhard Herlyn, Jianxin You |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/9/2/35 |
Similar Items
-
Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
by: Siti Fairus Abdul Rahman, et al.
Published: (2020-07-01) -
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
by: Jing-dong Zhou, et al.
Published: (2019-06-01) -
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
by: Alice C. O’Farrell, et al.
Published: (2020-10-01) -
Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice
by: Yicheng He, et al.
Published: (2021-10-01) -
From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis
by: Nathan A. Krump, et al.
Published: (2021-09-01)